Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation-Reference-Cited by-同舟云学术

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation

Published:2016-05-05 Issue:23 Volume:7 Page:35293-35301
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chomel Jean Claude¹²,Bonnet Marie Laure²,Sorel Nathalie¹²,Sloma Ivan³⁴⁵,Bennaceur-Griscelli Annelise³⁴⁵,Rea Delphine⁶⁷,Legros Laurence⁸,Marfaing-Koka Anne⁹,Bourhis Jean-Henri⁹¹⁰,Ame Shanti¹¹,Guerci-Bresler Agnès¹²,Rousselot Philippe¹³¹⁴,Turhan Ali G.²³⁴⁵¹⁵

Affiliation:

1. Laboratoire de Cancérologie Biologique, CHU de Poitiers, Poitiers, France

2. INSERM U935, Poitiers, France

3. Service d'Hématologie Biologique, Hôpital Paul Brousse, Villejuif, France

4. INSERM U935, Villejuif, France

5. Université Paris Sud, Le Kremlin-Bicêtre, France

6. Service d'Hématologie Adulte, Hôpital Saint Louis, Paris, France

7. INSERM UMRS-1160, IUH-Université Paris Diderot-Paris 7, Paris, France

8. Service d'Hématologie Clinique, Hôpital l'Archet, Nice, France

9. Service d'Hématologie Biologique, Hôpital Antoine Béclère, Clamart, France

10. Service d'Hématologie-Greffe de Moelle, Institut Gustave Roussy, Villejuif, France

11. Département d'Hématologie et Oncologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

12. Service d'Hématologie Clinique, CHU Brabois, Vandoeuvre les Nancy, France

13. Service d'Hématologie et Oncologie, Centre Hospitalier de Versailles, Versailles, France

14. EA4340, Université Versailles-Saint Quentin en Yvelines, Université Paris-Saclay, France

15. Service d'Hématologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gallic Acid Enhances the Efficacy of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia through Inhibition of Mitochondrial Respiration and Modulation of Oncogenic Signaling Pathways;International Journal of Molecular Sciences;2024-07-21

2. Lycorine attenuated proliferation and induced apoptosis on imatinib-resistant K562 cell by inhibiting autophagy;Discover Oncology;2024-06-10

3. Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche;Nature Communications;2024-02-05

4. Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model;Frontiers in Immunology;2024-01-08

5. CDK8/19 Inhibition Attenuates G1 Arrest Induced by BCR-ABL Antagonists and Accelerates Death of Chronic Myelogenous Leukemia Cells;2023-09-25